SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 1.050+7.1%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Eracist who wrote (9769)7/20/1998 6:38:00 PM
From: Scott H. Davis  Read Replies (1) of 14328
 
Eracist - watch outstanding shares on a fully diluted basis. No way to make a projection now due to their history of cranking paper/granting options. If by qtr 1 1999 report, shares outstanding are < 25m & revenues continue to increase, then $2.5 - $3.00 a year out is possible, based on hitting .03 EPS unrounded by qtr1 with a clear enough trend that investors would have confidence that by qtr 4 1999 EPS would be up to .04 unrounded.

Those prices would disapoint a lot of people, but considering that would represent a > 25-50% return from today's price, not a bad return.

It will take some time to re-establish credibility with investors. Financing an expansion with discounted convertibles was no-bueno.
And time to verify that management is acting with self-discipline & show that it takes shareholder interests seriously based on actions rather than words.

Company still has potential IF they can somehow restrain themselves in regards to shares. IMSCO Scott

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext